#8584. Erratum: Correction (Artificial cells, nanomedicine, and biotechnology (20XX) 47 1 (3885-3895))

December 2026publication date
Proposal available till 30-05-2025
4 total number of authors per manuscript4500 $

The title of the journal is available only for the authors who have already paid for
Journal’s subject area:
Pharmaceutical Science;
Medicine (miscellaneous);
Biomedical Engineering;
Biotechnology;
Places in the authors’ list:
place 1place 2place 3place 4
FreeFreeFreeFree
1350 $1200 $1050 $900 $
Contract №8584.1 Contract №8584.2 Contract №8584.3 Contract №8584.4
1 place - free (for sale)
2 place - free (for sale)
3 place - free (for sale)
4 place - free (for sale)

Abstract:
In this study, we demonstrated that down-regulated miR-3194-3p was associated with adverse prognostic features of hepatocellular carcinoma patients.
Keywords:
hepatocellular carcinoma; miR-3194-3p; clinical prognosis; in vivo

Contacts :
0